- VernacularTitle:二甲双胍治疗银屑病的研究进展
- Author:
Xiaomin CHEN
1
;
Jingzhan ZHANG
;
Yuan DING
;
Xiaojing KANG
Author Information
- Keywords: Psoriasis; Metformin; Therapy; NF-kappa B; Mechanistic target of rapamycin; Extracellular signal-regulated kinase 1/2; Signal transducing activator of trans
- From: Chinese Journal of Dermatology 2023;56(8):799-802
- CountryChina
- Language:Chinese
- Abstract: Metformin, the first-line treatment of type 2 diabetes, has been also increasingly used in the treatment of some skin diseases, such as psoriasis. This review summarizes therapeutic mechanisms of and clinical research progress in metformin in the treatment of psoriasis, aiming to provide ideas and methods for the treatment of psoriasis, especially psoriasis complicated by metabolic diseases.